Mirum Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $294.7M
Liabilities Breakdown FY2021
Total Liabilities: $174.4M
Asset Breakdown
Total Assets: $294.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $31.3M | 10.6% |
| Accounts Receivable | $3.3M | 1.1% |
| Inventory | $1.5M | 0.5% |
| Property, Plant & Equipment | $981.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $18.7M | 6.4% |
| Other Assets | $238.8M | 81.0% |
Liabilities Breakdown
Total Liabilities: $174.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.2M | 5.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $165.3M | 94.7% |